Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-03-20
2007-03-20
Zucker, Paul A (Department: 1621)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S247000, C514S403000, C540S545000, C540S554000, C540S604000, C540S605000, C544S224000, C548S356100
Reexamination Certificate
active
10537346
ABSTRACT:
Compounds of formula (I) have antibacterial activity; wherein Q represents a radical of formula —N(OH)CH(═O) or formula —C(═O)NH(OH); Y represents —C(═O)—, —C(═S)—, —S(═O)—, or —SO2—; R1represents hydrogen, C1–C6alkyl or C1–C6alkyl substituted by one or more halogen atoms, or, except when Q is a radical of formula —N(OH)CH(═O), a hydroxy, C1–C6alkoxy, C1–C6alkenyloxy, halogen, amino, C1–C6alkylamino, or di-(C1–C6alkyl)amino group; R2represents a substituted or unsubstituted C1–C6alkyl, C1–C3alkyl-O—C1–C3alkyl, C1–C3alkyl-S—C1–C3alkyl, cycloalkyl(C1–C3alkyl)-, aryl(C1–C3alkyl)-, heterocyclyl(C1–C3alkyl)-, or R1R2N—C1–C3alkyl group wherein R1represents hydrogen or C1–C3alkyl and R2represents C1–C3alkyl, or R1R2N-represents a cyclic amino group; R3and R4taken together with the nitrogen atoms to which they are respectively attached form a saturated heterocyclic ring of from 4 to 7 ring atoms, which may be fused to a second carbocyclic or heterocyclic ring, either of which rings may optionally be substituted; and A represents a primary, secondary or tertiary amino group or a group —R5, —OR5, wherein R5is a substituted or unsubstituted C1–C6alkyl, C2–C6alkenyl, C2–C6alkynyl, cycloalkyl, aryl, heterocyclyl, C1–C3alkyl-O—C1–C3alkyl, C1–C3alkyl-S—C1–C3alkyl, cycloalkyl(C1–C3alkyl)-, heterocyclic(C1–C3alkyl, aryl(C1–C3alkyl)-or R1R2N—C1–C3alkyl group wherein R1represents hydrogen or C1–C3alkyl and R2represents C1–C3alkyl, or R1R2N-represents a cyclic amino group
REFERENCES:
patent: WO 95 29892 (1995-11-01), None
patent: WO 95 33731 (1995-12-01), None
K. Tamaki et al.: “Synthesis and Structure-Activity Relationships of Gelatinase Inhibitors” Chemical and Pharmaceutical Bulletin., vol. 43, No. 11, 1995, pp. 1883-1893, XP002165817 Pharmaceutical Societe of Japan. Tokyo., JP, ISSN: 0009-2363 p. 1883; example 29-31.
Vernalis (Oxford) Limited
Zucker Paul A
LandOfFree
Antibacterial agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibacterial agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibacterial agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3721150